Bausch + Lomb Corporation (TSX: BLCO)

Canada flag Canada · Delayed Price · Currency is CAD
26.87
+0.93 (3.59%)
Dec 20, 2024, 4:09 PM EST
30.69%
Market Cap 9.11B
Revenue (ttm) 6.33B
Net Income (ttm) -497.15M
Shares Out n/a
EPS (ttm) -1.41
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,912
Open 25.87
Previous Close 25.94
Day's Range 25.65 - 26.87
52-Week Range 18.11 - 29.37
Beta 0.48
Analysts n/a
Price Target n/a
Earnings Date Feb 21, 2025

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and ... [Read more]

Sector Healthcare
Founded 1853
Employees 13,300
Stock Exchange Toronto Stock Exchange
Ticker Symbol BLCO
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

Bausch + Lomb Corporation (BLCO) Q3 2024 Earnings Call Transcript

Bausch + Lomb Corporation (NYSE:BLCO) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Br...

7 weeks ago - Seeking Alpha

Bausch + Lomb Stock Pops as TPG, Blackstone Consider Joint Bid

Bausch + Lomb Corporation (BLCO) shares popped Monday morning following reports Blackstone (BX) and TPG (TPG) are considering teaming up to buy the eyecare company.

2 months ago - Investopedia

Overlooked Stock: BLCO

Bausch + Lomb (BLCO) closed on a 52-week high following reports of the company planning to sell itself. George Tsilis explains why this led to a rally for the medical services company.

3 months ago - Schwab Network

Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues

Bausch + Lomb Corp (NYSE: BLCO) is reportedly considering a sale as it navigates separation issues from its parent company, Bausch Health Companies (NYSE: BHC). The potential sale is part of efforts...

3 months ago - Benzinga

Bausch + Lomb Stock Jumps Amid Reports Of A Sale

Bausch + Lomb (BLCO) shares popped Monday following a report that the eyecare company is considering a sale.

3 months ago - Investopedia

Bausch + Lomb Soars on Report That It’s Exploring a Sale

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company.

3 months ago - BNN Bloomberg

Bausch + Lomb Corporation (BLCO) Q2 2024 Earnings Call Transcript

Bausch + Lomb Corporation (NYSE:BLCO) Q2 2024 Earnings Call July 31, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President, Investor Relations Brent Saunders - Chairman and Chief Exe...

5 months ago - Seeking Alpha

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...

6 months ago - Business Wire

Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. intro...

6 months ago - Business Wire

Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launc...

7 months ago - Business Wire

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “Company”), a leading global eye health company dedicated to helping people see better to live bet...

7 months ago - Business Wire

Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting®

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...

7 months ago - Business Wire

Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Health Ca...

7 months ago - Business Wire

Bausch + Lomb Corporation (BLCO) Q1 2024 Earnings Call Transcript

Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants George Gadkowski - VP, IR & Business Insights Brent Saunders - Chairman & CEO Sam El...

8 months ago - Seeking Alpha

Bausch + Lomb Announces First-Quarter 2024 Results

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its first-quar...

8 months ago - Business Wire

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentati...

8 months ago - Business Wire

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced Frontiers in O...

8 months ago - Business Wire

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its ONE by ONE...

8 months ago - Business Wire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter...

8 months ago - Business Wire

Bausch + Lomb Stock Jumps After Better-Than-Expected Earnings, Guidance (Investopedia)

A big jump in pharmaceutical sales helped eye-care products maker Bausch + Lomb Corp. beat profit and sales estimates for the fourth quarter.

10 months ago - Investopedia

Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript

Bausch + Lomb Corporation (BLCO) Q4 2023 Earnings Call Transcript

10 months ago - Seeking Alpha

Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses

Bausch + Lomb Corp (NYSE: BLCO) reported the fourth quarter of 2023 sales of $1.173 billion, up 18% year-on-year (Y/Y), beating the consensus of $1.02 billion . Excluding the unfavorable impact of fo...

10 months ago - Benzinga

Bausch & Lomb's stock soars 11% after earnings beat

Bausch + Lomb Corp.'s stock soared 10% early Wednesday, after the vision-care company's adjusted fourth-quarter profit topped estimates and it offered upbeat revenue guidance for 2024.

10 months ago - Market Watch

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

Bausch + Lomb Corp at JPMorgan Healthcare Conference Transcript

11 months ago - GuruFocus

Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript

Bausch + Lomb Corp at Morgan Stanley Global Healthcare Conference Transcript

11 months ago - GuruFocus